Market Overview

Citigroup Reiterates Buy Rating, $60 PT on CVS Caremark Corporation

Related CVS
Fast Money Traders Share 4 Stocks That Are Going To Reach Their Highs
Fast Money Picks For September 22

In a report published Monday, Citigroup reiterated its Buy rating and $60.00 price target on CVS Caremark Corporation (NYSE: CVS).

Citigroup noted, “We expect investors to focus on: 1) WAG/ESRX script retention; 2) the 2013 PBM selling season; 3) PBM streamlining initiatives; 4) opportunities to drive utilization, incl. Maintenance Choice (MC), generics, and healthcare reform; 5) specialty; 6) int'l expansion; and 7) capital allocation. CVS's unique business model continues to gain traction, and we anticipate optimistic 2013 guidance to be provided. CVS is Buy-rated and on Citi's Top Picks Live! list.”

CVS Caremark Corporation closed on Friday at $47.23.

Latest Ratings for CVS

Aug 2015OppenheimerMaintainsOutperform
Jun 2015OppenheimerInitiates Coverage onOutperform
Jun 2015Cowen & CompanyMaintainsOutperform

View More Analyst Ratings for CVS
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Reiteration Analyst Ratings


Related Articles (CVS)

Get Benzinga's Newsletters